Metraipolis › archive › dc_f504a40adbae

Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): a phase II study (NIRA-PANC) — Europe PMC PMID:42249558

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42249558
DOI
10.1093/oncolo/oyag225
License (as archived)
solo-consultazione
Archived
2026-10-18T13:38:19.701Z
SHA-256 of the archived text
e3b2e7fca8e485f17cbc8769e22aa7fe01589fcfde6f5bc50f51a666ccdb6d2e
Stable URL of this page
https://metraipolis.com/documento/dc_f504a40adbae

How to cite

Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): a phase II study (NIRA-PANC) — Europe PMC PMID:42249558 — Europe PMC (en), https://europepmc.org/article/MED/42249558 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f504a40adbae (Metraipolis archive dc_f504a40adbae, sha256 e3b2e7fca8e485f17cbc8769e22aa7fe01589fcfde6f5bc50f51a666ccdb6d2e)
BibTeX
@misc{dcf504a40adbae,
  title = {Niraparib in pancreatic cancer with germline or somatic DNA damage repair (DDR) gene alterations (BRCA and beyond): a phase II study (NIRA-PANC) — Europe PMC PMID:42249558},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42249558},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f504a40adbae; sha256 e3b2e7fca8e485f17cbc8769e22aa7fe01589fcfde6f5bc50f51a666ccdb6d2e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42249558. Agents can read the archived copy with the MCP tool read_document.